{
  "ticker": "ILA",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973333",
  "id": "02973333",
  "pages": 39,
  "price_sensitive": false,
  "date": "20250728",
  "time": "1322",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250728/pdf/06m6qmcqtqvjrk.pdf",
  "summary": "### Summary of ASX Announcement - Island Pharmaceuticals Limited (28 July 2025)  \n\n#### **Announcement Type**: Investor Roadshow & Presentation  \n- **Key Highlights from Investor Presentation**:  \n  - **Galidesivir Program**:  \n    - Broad-spectrum antiviral with activity against 20+ viruses (e.g., Marburg, Ebola, Zika).  \n    - Potential FDA approval via *Animal Rule* (one additional animal study required).  \n    - Priority Review Voucher (PRV) eligible\u2014potential value **US$103\u2013158M**.  \n    - Targeting completion of Marburg animal study by **Q4 2025**.  \n  - **ISLA-101 (Dengue)**:  \n    - Positive Phase 2a/b results: **reduced viral load** (-10\u201315x) and symptoms in prophylaxis cohort.  \n    - First molecule to show efficacy in SUNY Dengue Human Infection Model.  \n    - No approved dengue therapeutics globally\u2014**potential multi-billion-dollar market**.  \n  - **Financials**:  \n    - **Cash balance (30 June 2025)**: **$7.25M**.  \n    - Market cap: **$37.1M** (price: $0.15/share; 247.2M shares outstanding).  \n\n#### **Upcoming Catalysts**:  \n- **Galidesivir**: FDA meeting request (August 2025), Marburg study initiation (Q4 2025).  \n- **ISLA-101**: FDA discussions on Phase 3 design (Q4 2025), partner engagement ongoing.  \n\n#### **Roadshow**:  \n- Investor meetings in Australia (**30 July\u20135 August 2025**) and Bioshares Biotech Summit (**7\u20138 August 2025**).  \n\n*No material capital-raising or operational updates disclosed.*",
  "usage": {
    "prompt_tokens": 7606,
    "completion_tokens": 380,
    "total_tokens": 7986,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-28T04:37:01.740933"
}